Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,437 public trials 2,853 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

NCT07682792

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not yet recruiting

Hospital Based Continuous Patient Monitoring System

NCT06739447

Conditions: Appendectomy, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

NCT07681596

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Research Site Duarte, California, United States

Research Site Denver, Colorado, United States

Research Site Tampa, Florida, United States

Research Site Atlanta, Georgia, United States

View Trial Details

Not yet recruiting

EFFECT OF PLATELET CONCENTRATE TRANSFUSION ON MICROCIRCULATORY ENDOTHELIAL FUNCTION IN INTENSIVE CARE UNIT

NCT07682246

Conditions: Blood Platelet Disorders, Cytopenia, Endothelial Function, +5 more
Locations: Medical Intensive Care Unit, Saint-Antoine Hospital, AP-HP, Paris, France Paris, France

View Trial Details

Not yet recruiting

Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL：Stop Trial 2.0

NCT07682415

Conditions: CLL / SLL, Chronic Disease, Disease Attributes, +14 more
Locations: Shenzhen Second People's Hospital Shenzhen, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT07557056

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Not yet recruiting

BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies

NCT07679919

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations: Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Not yet recruiting

rhTPO Dose Escalation vs Eltrombopag Switch in ITP

NCT07476846

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

NCT07678307

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML

NCT07605949

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions